Clinical Trials on Melanoma in Situ
Total 68828 results
-
DermTechCompleted
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch...Active, not recruiting
-
Novartis PharmaceuticalsCompletedMetastatic MelanomaSwitzerland, United States
-
Medical University of GrazCompleted
-
AB ScienceTerminatedMetastatic MelanomaFrance, Spain, Italy, United States, Czechia, Germany, Russian Federation
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Immunocore LtdTerminated
-
Genentech, Inc.Completed
-
Immunocore LtdCompletedMalignant MelanomaUnited Kingdom, United States
-
Aduro Biotech, Inc.Terminated
-
Peking University Cancer Hospital & InstituteUnknown
-
NCIC Clinical Trials GroupCompleted
-
Inge Marie SvaneCompleted
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
Hoffmann-La RocheCompleted
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
University of California, IrvineTerminatedMetastatic MelanomaUnited States
-
AnewPharmaUnknownMucosal MelanomaChina
-
Hoffmann-La RocheCompleted
-
Peking University Cancer Hospital & InstituteUnknown
-
University Hospital, MontpellierSaint-Louis Hospital, Paris, FranceCompleted
-
Cliniques universitaires Saint-Luc- Université...Terminated
-
Universitair Ziekenhuis BrusselCompleted
-
AHS Cancer Control AlbertaTransplant Genomics, Inc.Unknown
-
Hoffmann-La RocheCompleted
-
Hadassah Medical OrganizationUnknown
-
Merck Sharp & Dohme LLCTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
John P. FruehaufBayerCompletedMetastatic MelanomaUnited States
-
American Regent, Inc.Completed
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCWithdrawn
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
National Human Genome Research Institute (NHGRI)Completed
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Centre Hospitalier Universitaire, AmiensUnknown
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
University of ZurichCompleted
-
University of PittsburghBristol-Myers SquibbWithdrawn